Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12326
CALL
NLI Holdings
NL
$340M
| $31.2K | ﹤0.01% |
4,200
+2,200
| +110% | +$14.1K |
2022 Q3
8 quarters
|
|
12327
PUT
NiSource
NI
$19.5B
| $31.2K | ﹤0.01% |
900
-54,300
| -98% | -$1.73M |
2020 Q1
18 quarters
|
|
|
BGI
12328
DELISTED
Birks Group
BGI
| $31.1K | ﹤0.01% |
+14,224
| New | +$35.7K |
2024 Q3
0 quarters
|
|
12329
PUT
AngioDynamics
ANGO
$606M
| $31.1K | ﹤0.01% |
+4,000
| New | +$28.9K |
2024 Q3
0 quarters
|
|
12330
CALL
Stem
STEM
$45.9M
| $31K | ﹤0.01% |
4,455
+60
| +1% | +$944 |
2020 Q4
15 quarters
|
|
12331
CALL
Ironwood Pharmaceuticals
IRWD
$600M
| $30.9K | ﹤0.01% |
7,500
+3,700
| +97% | +$19.9K |
2022 Q4
7 quarters
|
|
12332
PUT
Playboy Inc
PLBY
$125M
| $30.9K | ﹤0.01% |
40,700
-1,900
| -4% | -$1.36K |
2021 Q1
14 quarters
|
|
12333
Euro Tech Holdings
CLWT
$9.49M
| $30.8K | ﹤0.01% |
+18,910
| New | +$29.4K |
2024 Q3
0 quarters
|
|
|
MURA
12334
DELISTED
Mural Oncology
MURA
| $30.7K | ﹤0.01% |
9,820
-12,688
| -56% | -$41.3K |
2023 Q4
3 quarters
|
|
12335
PUT
Kforce
KFRC
$908M
| $30.7K | ﹤0.01% |
500
-200
| -29% | -$12.8K |
2022 Q3
8 quarters
|
|
|
IMVP
12336
PUT
Invesco India ETF
IMVP
$94.1M
| $30.7K | ﹤0.01% |
+1,000
| New | +$29.9K |
2024 Q3
0 quarters
|
|
12337
CALL
Hayward Holdings
HAYW
$2.61B
| $30.7K | ﹤0.01% |
2,000
-8,100
| -80% | -$112K |
2021 Q2
13 quarters
|
|
12338
CALL
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$626M
| $30.7K | ﹤0.01% |
400
-400
| -50% | -$31.5K |
2022 Q2
9 quarters
|
|
|
CLSD
12339
CALL
DELISTED
Clearside Biomedical
CLSD
| $30.6K | ﹤0.01% |
1,607
+434
| +37% | +$7.41K |
2020 Q3
16 quarters
|
|
|
IVAC
12340
PUT
DELISTED
Intevac Inc
IVAC
| $30.6K | ﹤0.01% |
9,000
+2,500
| +38% | +$9.1K |
2022 Q1
10 quarters
|
|
12341
PUT
iShares MSCI Emerging Markets ex China ETF
EMXC
$26.3B
| $30.6K | ﹤0.01% |
500
-600
| -55% | -$36K |
2022 Q3
8 quarters
|
|
12342
CALL
Acadia Realty Trust
AKR
$2.53B
| $30.5K | ﹤0.01% |
1,300
+600
| +86% | +$12.8K |
2022 Q4
7 quarters
|
|
12343
OneMedNet
ONMD
$28.9M
| $30.5K | ﹤0.01% |
+4,990
| New | +$48.2K |
2024 Q3
0 quarters
|
|
|
CAPT
12344
CALL
DELISTED
Captivision
CAPT
| $30.5K | ﹤0.01% |
15,400
+8,400
| +120% | +$18.3K |
2024 Q2
1 quarter
|
|
|
WIMI
12345
CALL
WiMi Hologram Cloud
WIMI
$13.4M
| $30.5K | ﹤0.01% |
2,960
+1,280
| +76% | +$10.5K |
2020 Q4
15 quarters
|
|
12346
CALL
Coherus Oncology
CHRS
$159M
| $30.5K | ﹤0.01% |
29,300
-1,400
| -5% | -$1.92K |
2022 Q4
7 quarters
|
|
|
GENE
12347
CALL
DELISTED
Genetic Technologies Ltd.
GENE
| $30.5K | ﹤0.01% |
+40,700
| New | +$36.2K |
2024 Q3
0 quarters
|
|
|
BBUC
12348
CALL
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.38B
| $30.4K | ﹤0.01% |
1,200
+500
| +71% | +$11K |
2024 Q1
2 quarters
|
|
|
ADAM
12349
PUT
Adamas Trust
ADAM
$694M
| $30.4K | ﹤0.01% |
4,800
+200
| +4% | +$1.29K |
2017 Q4
27 quarters
|
|
12350
PUT
Pangaea Logistics
PANL
$551M
| $30.4K | ﹤0.01% |
4,200
+1,500
| +56% | +$10.4K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.